News Articles

Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.

Filters
Clear all
Showing 0 of 100
Keyword Search
Open Arrow
Article Type
Open Arrow
Company
Open Arrow
Clear all
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Close Icon

Algernon Pharmaceuticals Announces Database Lock in Phase 2 Study of IPF and Chronic Cough

News
June 13, 2022
Algernon Pharmaceuticals

Psychedelic Weekly Headlines | June 10th

Headlines
June 10, 2022
Cybin Inc.
Tryp Therapeutics
Pharmather
Nova Mentis Life Science
Optimi Health

Mindset Pharma Receives Notice of Allowance for Patent Application Covering Psilocin Derivatives for the Treatment of Central Nervous System Disorders

News
June 10, 2022
Mindset Pharma

Filament Health Cultivates 70th Psychedelic Mushroom Variety And Announces Annual General Meeting

News
June 10, 2022
Filament Health

Wellbeing subsidiary KGK Science and the International Probiotics Association (“IPA”) applauds FDA’s Commitment to Release NDI Draft Guidance Documents in the Near Future

News
June 9, 2022
Wellbeing Digital Sciences

Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

News
June 9, 2022
Small Pharma

Cybin Receives Institutional Review Board Approval for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder

News
June 9, 2022
Cybin Inc.

Nirvana Life Sciences Announces Patent Filing

News
June 9, 2022
Nirvana Life Sciences

Tryp Therapeutics Announces Results Of First Patient Dosed In Its Phase Ii Clinical Trial For The Treatment Of Binge Eating Disorder

News
June 9, 2022
Tryp Therapeutics

Filament Health and Jaguar Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications

News
June 9, 2022
Filament Health

Silo Wellness Issues Shareholder Letter and Announces New Chief Executive Officer

News
June 9, 2022
Silo Wellness

Nova Mentis and University of Central Florida to Develop Saliva Serotonin Assay

News
June 9, 2022
Nova Mentis Life Science

Mydecine Provides Company Update; Welcomes New Board Member

News
June 9, 2022
Mydecine Innovations Group

Novamind Shareholders Approve Proposed Acquisition by Numinus

News
June 8, 2022
Novamind Inc.
Numinus

Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

News
June 8, 2022
Wesana Health

Optimi Health Finalizes Partnership and Psilocybin Supply Agreement With ATMA Journey Centers

News
June 8, 2022
Optimi Health

Mindset Pharma to Participate in Upcoming Conferences in June 2022

News
June 7, 2022
Mindset Pharma

Awakn Life Sciences Appoints Biotech and Investment Veteran Dennis Purcell as a Special Advisor to the CEO

News
June 7, 2022
Awakn Life Sciences

Entheon Announces Sale of Certain DMT Clinical Assets and Filing of Provisional Novel Compound Patents

News
June 7, 2022
Entheon Biomedical

SciSparc Ltd. Announces Initial Positive Results for the Cocaine Addiction Treatment of Clearmind Medicine Inc.

News
June 7, 2022
Clearmind Medicine
No results found.
There are no results with this criteria. Try changing your search.
HomeNewsCompaniesSpotlightsSubscribe
Instagram
Twitter
RSS Feed
Email Us
©XXXX Psychedelic Finance. All rights reserved.
Privacy Policy
Core One Labs Inc.
Creso Pharma
Cybin Inc.
Enveric Biosciences
Field Trip Health
Filament Health
Havn Life
Levitee Labs
MINDCURE
Mydecine Innovations Group
NeonMind Biosciences Inc.
Novamind Inc.
Numinus
Optimi Health
Pharmather
PsyBio Therapeutics
Psyched Wellness
Psyence Group
Pure Extracts Corp
Silo Wellness
The Good Shroom Co
Tryp Therapeutics
Wesana Health
Aja Ventures
Albert Labs
Algernon Pharmaceuticals
Apex Labs Ltd.
B.More
Beckley Foundation
BetterLife Pharma
Bexson Biomedical
Biomind Labs
Bionomics
Braxia Scientific Corp.
Bright Minds
CB Therapeutics
Ceruvia Lifesciences
Clairvoyant Therapeutics
Clearmind Medicine
Clexio Biosciences
Cognetivity Neurosciences
Cube Psytech
Delic
Delix Therapeutics
Diamond Therapeutics
Ehave
FSD Pharma
Fluence
Freedom to Operate
HMNC Brain Health
Horizons ETFs Management Inc.
Incannex Healthcare
IntelGenx
Irwin Naturals
Ixtlan Bioscience
Johns Hopkins Medicine
MYND Diagnostics
Mind Medicine (MindMed)
MindBio Therapeutics
Mindset Pharma
Mycotopia Therapies
Mycrodose Therapeutics
Neural Therapeutics
Ninnion
Nirvana Life Sciences
Nova Mentis Life Science
Origin Therapeutics
Osmind
Pasithea Therapeutics
Pharmala Biotech Holdings
Psilera
Psilotec Health Solutions
PsyRx
Psylo
Quantified Citizen
Reunion Neuroscience
Revitalist Lifestyle and Wellness
Revive Therapeutics
Seelos Therapeutics
Small Pharma
Telescope Innovations
TheraPsil
TripSitter
Universal Ibogaine
Wellbeing Digital Sciences
Woke Pharmaceuticals
Woven Science
ATAI Life Sciences
Awakn Life Sciences
Beckley Psytech
Compass Pathways
Doseology Sciences
EI.ventures
Eleusis
Entheon Biomedical
Gilgamesh Pharmaceuticals
GoodCap Wellness
Lobe Sciences
Lophora
MAPS